Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 129 of the 130 references it cites were found in a registry or an index; 79 of the 234 sources its claims cite were checked for support.

Exploring the Lesser-Known Bioactive Natural Products of Plant Species of the Genus Cannabis L.: Alkaloids, Phenolic Compounds, and Their Therapeutic Potential

Open access
Boucher, Raphaël, Germain, Hugo, Desgagné-Penix, Isabel · 2025 · Plants

Abstract

Plant species of the genus Cannabis L. are predominantly recognized for their cannabinoids, which have garnered significant attention due to their bioactive properties. However, Cannabis also produces a diverse array of bioactive compounds with promising pharmacological potential that remain underexplored. This review focuses primarily on phytochemicals derived from Cannabis sativa L. subspecies, including both its drug-type and fiber-type varieties, which are the most widely cultivated and studied within the genus. Among these, nitrogen-containing compounds such as spermidine alkaloids exhibit neuroprotective and anti-aging properties, while hydroxycinnamic acids and hydroxycinnamic acid amides, including N-trans-caffeoyltyramine and N-trans-feruloyltyramine, have demonstrated notable antioxidant and anti-inflammatory activities. Additionally, Cannabis species are a valuable source of unique stilbenes, such as canniprene, and flavonoids, including cannflavin A and B, which demonstrated potent anti-inflammatory and antiproliferative effects. Despite this rich phytochemical diversity, research on these compounds remains limited, largely due to historical legal restrictions. This literature review consolidates and updates current knowledge on these lesser-studied phytochemicals of Cannabis, detailing their biosynthetic pathways, metabolic precursors, and emerging therapeutic applications. By expanding the research focus beyond cannabinoids, this work aims to enhance our understanding of Cannabis’s full pharmacological potential and promote further investigation into its diverse chemical constituents.

Overview

CoChat Summary

TL;DR

This is a narrative review of lesser-known Cannabis metabolites beyond cannabinoids, focusing on nitrogen-containing compounds, flavonoids, and stilbenes, and summarizing their biosynthesis and reported bioactivities. The paper argues that these compounds have meaningful therapeutic potential, but research remains limited by historical cannabinoid bias, legal constraints, and thin regulatory guidance.

Key findings

  • The review reports that Cannabis contains 10 identified alkaloids and 15 phenolic amides/lignanamides, plus numerous flavonoids and stilbenes; it also states that 38 stilbenes have been identified in Cannabis.
  • For flavonoids, the paper highlights cannflavin A and B as especially potent anti-inflammatory compounds, stating they are 30 times more potent than acetylsalicylic acid in inhibiting prostaglandin/leukotriene production, and gives quantified levels such as 21–280 mg/kg for cannflavin A and 9–106 mg/kg for cannflavin B in pre-flowering leaves, and 19.6–130.0 mg/kg and 11.9–215.5 mg/kg across some hemp cultivars.
  • For nitrogen-containing compounds, the paper notes hordenine’s antibacterial and anti-inflammatory effects, including MIC = 2.5 mg/mL against *Pseudomonas aeruginosa* PAO1 and 69%, 74%, and 79% reductions in one quorum-sensing signal at 0.5, 0.75, and 1.0 mg/mL; it also reports N-trans-coumaroyltyramine reduced living cells by 40% in U937 and 32% in Jurkat at 30 μM.
  • For stilbenes, the paper reports denbinobin as antiproliferative and anti-metastatic, including 48.4% and 56.1% decreases in A549 viability at 10 and 20 μM, and anti-inflammatory activity for canniprene with IC50 = 0.4 μM against lipoxygenase 5.

Methods

  • Narrative literature review of Cannabis lesser-known metabolites, with emphasis on Cannabis sativa L. subspecies and especially roots, leaves, flowers, seeds, and stems.
  • PubMed searches were performed using metabolite- and activity-specific terms; when article counts were high, the review prioritized the most recent 10 years, and it included only purified compounds, excluding plant-extract activity studies.
  • The review synthesizes evidence on biosynthetic pathways, metabolic precursors, biological activities, and regulatory considerations; it also states that figures were created with ChemDraw version 22.2.0.3300.

Limitations

  • The paper explicitly says research on these compounds remains limited because of historical legal restrictions, research bias toward cannabinoids, and the absence of comprehensive regulatory frameworks.
  • It also states that for some compound classes, there is little biosynthetic or bioactivity information, especially for spermidine-type alkaloids and lignanamides.
  • Evident from the text: this is a narrative review rather than a systematic review or primary study, and it relies on published purified-compound studies, so its conclusions depend on the quality and availability of prior reports.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3390/plants14091372

Cites

129 of 129 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Overview of the primary to specialized metabolic flow in Cannabis. Plants synthesize metabolites through photosynthesis, which serves as foundational source for both primary and specialized metabolites. Primary metabolites, produced through essential pathways such as glycolysis, tricarboxylic acid cycle (TCA), shikimate pathway, and urea cycle, provide precursors for specialized metabolite biosynthesis. This diagram highlights key cannabinoids (blue), terpenoids (green), and nitrogen-containing (orange) and phenolic (purple) compound pathways, with examples of metabolites frequently found in Cannabis further detailed in Section 3. A solid arrow represents one enzymatic reaction (bold abbreviation next to it is the name of the enzyme), whereas a dashed arrow indicates sequences of multiple reactions. The figure is adapted from schemes by Flores-Sanchez and Verpoorte (2008) [29]. Abbreviations are found in Appendix A—Table A1, Table A2, Table A3, Table A4 and Table A5.
Figure 1 Overview of the primary to specialized metabolic flow in Cannabis. Plants synthesize metabolites through photosynthesis, which serves as foundational source for both primary and specialized metabolites. Primary metabolites, produced through essential pathways such as glycolysis, tricarboxylic acid cycle (TCA), shikimate pathway, and urea cycle, provide precursors for specialized metabolite biosynthesis. This diagram highlights key cannabinoids (blue), terpenoids (green), and nitrogen-containing (orange) and phenolic (purple) compound pathways, with examples of metabolites frequently found in Cannabis further detailed in Section 3. A solid arrow represents one enzymatic reaction (bold abbreviation next to it is the name of the enzyme), whereas a dashed arrow indicates sequences of multiple reactions. The figure is adapted from schemes by Flores-Sanchez and Verpoorte (2008) [29]. Abbreviations are found in Appendix A—Table A1, Table A2, Table A3, Table A4 and Table A5.CC BY · PubMed Central
Figure 2 Examples of nitrogen-containing specialized metabolites identified in Cannabis.
Figure 2 Examples of nitrogen-containing specialized metabolites identified in Cannabis.CC BY · PubMed Central
Figure 3 Aromatic amino acid biosynthetic pathway in plants. CM, chorismate mutase (* engaging step of the pathway). Arrow represents one biochemical reaction. PPA-AT, prephenate aminotransferase. ADT, arogenate dehydratase. ADH, arogenate dehydrogenase. In red: inhibition regulatory pathways. Glu, glutamate. Chorismate is converted to prephenic acid by the enzyme chorismate mutase (E.C. 5.4.99.5). Prephenate undergoes transamination by the enzyme prephenate aminotransferase (E.C. 2.6.1.79), using glutamate, producing L-arogenate and 2-oxoglutarate. The enzyme arogenate dehydratase (E.C. 4.2.1.91) completes the aromatic ring of the L-arogenate cycle by removing the hydroxyl and carboxylic groups attached to it, thus forming phenylalanine and generating H2O and CO2. To obtain tyrosine, arogenate is oxidized by the enzyme arogenate dehydrogenase (E.C. 1.3.1.43) with the cofactor NAD+, producing a molecule of CO2 and one of NADH.
Figure 3 Aromatic amino acid biosynthetic pathway in plants. CM, chorismate mutase (* engaging step of the pathway). Arrow represents one biochemical reaction. PPA-AT, prephenate aminotransferase. ADT, arogenate dehydratase. ADH, arogenate dehydrogenase. In red: inhibition regulatory pathways. Glu, glutamate. Chorismate is converted to prephenic acid by the enzyme chorismate mutase (E.C. 5.4.99.5). Prephenate undergoes transamination by the enzyme prephenate aminotransferase (E.C. 2.6.1.79), using glutamate, producing L-arogenate and 2-oxoglutarate. The enzyme arogenate dehydratase (E.C. 4.2.1.91) completes the aromatic ring of the L-arogenate cycle by removing the hydroxyl and carboxylic groups attached to it, thus forming phenylalanine and generating H2O and CO2. To obtain tyrosine, arogenate is oxidized by the enzyme arogenate dehydrogenase (E.C. 1.3.1.43) with the cofactor NAD+, producing a molecule of CO2 and one of NADH.CC BY · PubMed Central
Figure 4 General phenylpropanoid pathway up to cinnamic acid thioesters’ biosynthesis. (* engaging step of the pathway). Red-dotted box: alternative pathway for p-coumaric acid biosynthesis. Arrow represents one biochemical reaction. PAL, phenylalanine ammonia-lyase. TPAL, tyrosine/phenylalanine ammonia-lyase. C4H, cinnamate 4-hydroxylase. 4CL, 4-coumarate-CoA-ligase. Phenylalanine will undergo deamination by the enzyme phenylalanine ammonia-lyase (E.C. 4.3.1.24), which generates a molecule of NH3 and trans-cinnamic acid. Tyrosine/phenylalanine ammonia-lyase (E.C. 4.3.1.25) can realise the same reaction as PAL and can also convert tyrosine into p-coumaric acid. Cinnamate 4-hydroxylase (E.C. 1.14.14.91) adds a hydroxyl group to the para position of trans-cinnamic acid, generating p-coumaric acid. 4-coumarate-CoA-ligase (E.C. 6.2.1.12) uses an ATP molecule to convert p-coumaric acid to p-coumaroyl-CoA, releasing an AMP and a pyrophosphate molecule.
Figure 4 General phenylpropanoid pathway up to cinnamic acid thioesters’ biosynthesis. (* engaging step of the pathway). Red-dotted box: alternative pathway for p-coumaric acid biosynthesis. Arrow represents one biochemical reaction. PAL, phenylalanine ammonia-lyase. TPAL, tyrosine/phenylalanine ammonia-lyase. C4H, cinnamate 4-hydroxylase. 4CL, 4-coumarate-CoA-ligase. Phenylalanine will undergo deamination by the enzyme phenylalanine ammonia-lyase (E.C. 4.3.1.24), which generates a molecule of NH3 and trans-cinnamic acid. Tyrosine/phenylalanine ammonia-lyase (E.C. 4.3.1.25) can realise the same reaction as PAL and can also convert tyrosine into p-coumaric acid. Cinnamate 4-hydroxylase (E.C. 1.14.14.91) adds a hydroxyl group to the para position of trans-cinnamic acid, generating p-coumaric acid. 4-coumarate-CoA-ligase (E.C. 6.2.1.12) uses an ATP molecule to convert p-coumaric acid to p-coumaroyl-CoA, releasing an AMP and a pyrophosphate molecule.CC BY · PubMed Central
Figure 5 General biosynthesis of hydroxycinnamic acid amides from cinnamic acid thioesters. Blue-dotted boxes: some aminated molecules that can be condensed on a cinnamic acid moiety. Arrow represents one biochemical reaction. TYDC, tyrosine decarboxylase. ADC, arginine decarboxylase. PHT, putrescine N-hydroxycinnamoyltransferase. THT, hydroxycinnamoyl-CoA: tyramine N-(hydroxycinnamoyl)transferase. ACT, agmatine N4-coumaroyltransferase. Tyrosine decarboxylase (E.C. 4.1.1.25) produces tyramine and CO2 from tyrosine. Tryptamine decarboxylase (E.C. 4.1.1.105) produces tryptamine and CO2 from tryptophan. Putrescine N-hydroxycinnamoyltransferase (E.C. 2.3.1.138) produces a putrescine-derived hydroxycinnamic amide (e.g., N-p-coumaroylputrescine). Hydroxycinnamoyl-CoA:tyramine N-(hydroxycinnamoyl) transferase (E.C. 2.3.1.110) produces a tyramine-derived hydroxycinnamoyl acid amide (e.g., N-p-coumaroyltyramine). Agmatine N4-coumaroyltransferase (E.C. 2.3.1.64) produces an agmatine-derived hydroxycinnamic acid amide (e.g., N-p-coumaroylagmatine).
Figure 5 General biosynthesis of hydroxycinnamic acid amides from cinnamic acid thioesters. Blue-dotted boxes: some aminated molecules that can be condensed on a cinnamic acid moiety. Arrow represents one biochemical reaction. TYDC, tyrosine decarboxylase. ADC, arginine decarboxylase. PHT, putrescine N-hydroxycinnamoyltransferase. THT, hydroxycinnamoyl-CoA: tyramine N-(hydroxycinnamoyl)transferase. ACT, agmatine N4-coumaroyltransferase. Tyrosine decarboxylase (E.C. 4.1.1.25) produces tyramine and CO2 from tyrosine. Tryptamine decarboxylase (E.C. 4.1.1.105) produces tryptamine and CO2 from tryptophan. Putrescine N-hydroxycinnamoyltransferase (E.C. 2.3.1.138) produces a putrescine-derived hydroxycinnamic amide (e.g., N-p-coumaroylputrescine). Hydroxycinnamoyl-CoA:tyramine N-(hydroxycinnamoyl) transferase (E.C. 2.3.1.110) produces a tyramine-derived hydroxycinnamoyl acid amide (e.g., N-p-coumaroyltyramine). Agmatine N4-coumaroyltransferase (E.C. 2.3.1.64) produces an agmatine-derived hydroxycinnamic acid amide (e.g., N-p-coumaroylagmatine).CC BY · PubMed Central
Figure 6 Spermidine biosynthetic pathway. (A) General biosynthesis of putrescine. ODC, ornithine decarboxylase. Arrow represents one biochemical reaction. ADC, arginine decarboxylase. AIH, agmatine iminohydrolase. CPA, N-carbamoylputrescine amidase. Ornithine decarboxylase (E.C. 4.1.1.17) produces putrescine and CO2 from L-ornithine. Arginine decarboxylase (E.C. 4.1.1.19) produces agmatine and CO2 from L-arginine. Agmatine iminohydrolase (E.C. 3.5.3.12) produces N-carbamoylputrescine and NH3 from agmatine. N-carbamoylputrescine amidase (E.C. 3.5.1.53) produces putrescine through hydrolysis, generating NH3 and CO2 as well. (B) General biosynthesis of spermidine. SAMDC, S-adenosylmethionine decarboxylase. SPDS, spermidine synthase. S-adenosylmethionine decarboxylase (E.C. 4.1.1.50) produces S-adenosylmethioninamine and CO2 through decarboxylation of S-adenosyl-L-methionine. Spermidine synthase (E.C. 2.5.1.16) utilizes the aforementioned S-adenosylmethioninamine to transfer a propylamine group to putrescine, generating spermidine and S-methyl-5′-thioadenosine.
Figure 6 Spermidine biosynthetic pathway. (A) General biosynthesis of putrescine. ODC, ornithine decarboxylase. Arrow represents one biochemical reaction. ADC, arginine decarboxylase. AIH, agmatine iminohydrolase. CPA, N-carbamoylputrescine amidase. Ornithine decarboxylase (E.C. 4.1.1.17) produces putrescine and CO2 from L-ornithine. Arginine decarboxylase (E.C. 4.1.1.19) produces agmatine and CO2 from L-arginine. Agmatine iminohydrolase (E.C. 3.5.3.12) produces N-carbamoylputrescine and NH3 from agmatine. N-carbamoylputrescine amidase (E.C. 3.5.1.53) produces putrescine through hydrolysis, generating NH3 and CO2 as well. (B) General biosynthesis of spermidine. SAMDC, S-adenosylmethionine decarboxylase. SPDS, spermidine synthase. S-adenosylmethionine decarboxylase (E.C. 4.1.1.50) produces S-adenosylmethioninamine and CO2 through decarboxylation of S-adenosyl-L-methionine. Spermidine synthase (E.C. 2.5.1.16) utilizes the aforementioned S-adenosylmethioninamine to transfer a propylamine group to putrescine, generating spermidine and S-methyl-5′-thioadenosine.CC BY · PubMed Central
Figure 7 Dihydroperiphyllin skeleton and similar Cannabis and Equisetum sp. alkaloids.
Figure 7 Dihydroperiphyllin skeleton and similar Cannabis and Equisetum sp. alkaloids.CC BY · PubMed Central
Figure 8 Structure of fatty acids potentially involved in the biosynthesis of spermidine alkaloids of Cannabis.
Figure 8 Structure of fatty acids potentially involved in the biosynthesis of spermidine alkaloids of Cannabis.CC BY · PubMed Central
Figure 9 Hypothetical biosynthetic pathway of cannabisativine and anhydrocannabisativine. ACL, acyl-CoA ligase. Arrow represents one biochemical reaction and dotted arrow represents unknown (?) putative reaction. NMT, N-myristoyltransferase. First step is thought to be a condensation between spermidine and a fatty acid, presumably myristic acid. The open-end nitrogen atom of spermidine would then be fixed on C-3 and C-7 of the myristoyl moiety. A series of oxidation would generate the end products cannabisativine and anhydrocannabisativine. The order in which those oxidation reactions occur still is unknown.
Figure 9 Hypothetical biosynthetic pathway of cannabisativine and anhydrocannabisativine. ACL, acyl-CoA ligase. Arrow represents one biochemical reaction and dotted arrow represents unknown (?) putative reaction. NMT, N-myristoyltransferase. First step is thought to be a condensation between spermidine and a fatty acid, presumably myristic acid. The open-end nitrogen atom of spermidine would then be fixed on C-3 and C-7 of the myristoyl moiety. A series of oxidation would generate the end products cannabisativine and anhydrocannabisativine. The order in which those oxidation reactions occur still is unknown.CC BY · PubMed Central
Figure 10 Intramolecular cyclization of chalcones and flavanone numbering.
Figure 10 Intramolecular cyclization of chalcones and flavanone numbering.CC BY · PubMed Central
Figure 11 General biosynthetic pathway of flavonoids from p-coumaroyl-CoA. Flavanone is in bold, to emphasize its precursor role to other flavonoids. Arrow represents one biochemical reaction. CHS, chalcone synthase. CHI, chalcone isomerase. IFS, isoflavone synthase. FNS, flavone synthase I and II. F3H, flavanone 3-dioxygenase. FLS, flavonol synthase. DFR, dihydroflavonol 4-reductase. LDOX, leucoanthocyanidin dioxygenase. UFGT, UDP-glucose–flavonol O-glucosyltransferase. Chalcone synthase (E.C.2.3.1.74) produces a chalcone from a phenylpropanoid thioester (e.g., p-coumaroyl-CoA) by addition and subsequent cyclization of 3 molecules of malonyl-CoA. Chalcone isomerase (E.C.5.5.1.6) produces a flavanone from a chalcone through an intramolecular cyclization of an oxygen of the malonyl portion of the chalcone with the double bond originating from coumaric acid (see Figure 10). Isoflavone synthase (E.C. 1.14.14.87) produces an isoflavone from a flavanone by migration of their aryl group, from C-2 to C-3, combined with an oxidation of C-2, resulting in the double bond formation between C-2 and C-3. Flavone synthase I and II (E.C. 1.14.20.5) (E.C. 1.14.19.76) produce flavones from flavanone by oxidizing C-2 and C-3, forming a double bond. Flavanone 3-dioxygenase (E.C. 1.14.11.9) produces a dihydroflavonol from a flavanone by oxidizing C-3 using oxoglutarate, resulting in a hydroxyl group. Flavonol synthase (E.C. 1.14.20.6) produces a flavonol from a dihydroflavonol by oxoglutarate-dependent oxidation of C-2 and C-3, resulting in a double bond. Dihydroflavonol 4-reductase (E.C. 1.1.1.219) produces a leucoanthocyanidin from a dihydroflavonol by reducing the ketone group to a hydroxyl. Leucoanthocyanidin dioxygenase (E.C. 1.14.20.4) produces anthocyanidin from leucoanthocyanidin by oxidation of the C ring, resulting in loss of hydroxyl groups and positive charge acquisition in the heterocycle. UDP-glucose–flavonol O-glucosyltransferase (E.C. 2.4.1.91) produces anthocyanin by addition of sugar moieties to anthocyanidins.
Figure 11 General biosynthetic pathway of flavonoids from p-coumaroyl-CoA. Flavanone is in bold, to emphasize its precursor role to other flavonoids. Arrow represents one biochemical reaction. CHS, chalcone synthase. CHI, chalcone isomerase. IFS, isoflavone synthase. FNS, flavone synthase I and II. F3H, flavanone 3-dioxygenase. FLS, flavonol synthase. DFR, dihydroflavonol 4-reductase. LDOX, leucoanthocyanidin dioxygenase. UFGT, UDP-glucose–flavonol O-glucosyltransferase. Chalcone synthase (E.C.2.3.1.74) produces a chalcone from a phenylpropanoid thioester (e.g., p-coumaroyl-CoA) by addition and subsequent cyclization of 3 molecules of malonyl-CoA. Chalcone isomerase (E.C.5.5.1.6) produces a flavanone from a chalcone through an intramolecular cyclization of an oxygen of the malonyl portion of the chalcone with the double bond originating from coumaric acid (see Figure 10). Isoflavone synthase (E.C. 1.14.14.87) produces an isoflavone from a flavanone by migration of their aryl group, from C-2 to C-3, combined with an oxidation of C-2, resulting in the double bond formation between C-2 and C-3. Flavone synthase I and II (E.C. 1.14.20.5) (E.C. 1.14.19.76) produce flavones from flavanone by oxidizing C-2 and C-3, forming a double bond. Flavanone 3-dioxygenase (E.C. 1.14.11.9) produces a dihydroflavonol from a flavanone by oxidizing C-3 using oxoglutarate, resulting in a hydroxyl group. Flavonol synthase (E.C. 1.14.20.6) produces a flavonol from a dihydroflavonol by oxoglutarate-dependent oxidation of C-2 and C-3, resulting in a double bond. Dihydroflavonol 4-reductase (E.C. 1.1.1.219) produces a leucoanthocyanidin from a dihydroflavonol by reducing the ketone group to a hydroxyl. Leucoanthocyanidin dioxygenase (E.C. 1.14.20.4) produces anthocyanidin from leucoanthocyanidin by oxidation of the C ring, resulting in loss of hydroxyl groups and positive charge acquisition in the heterocycle. UDP-glucose–flavonol O-glucosyltransferase (E.C. 2.4.1.91) produces anthocyanin by addition of sugar moieties to anthocyanidins.CC BY · PubMed Central
Figure 12 Biosynthesis of cannflavins. FNSI/II, flavone synthase I and II. F3′H, flavonoid 3′-hydroxylase. Arrow represents one biochemical reaction. SAM-MT, S-adenosyl-L-methionine methyltransferase. GT, geranyltransferase. PT, prenyltransferase. SAH, S-adenosyl-L-homocysteine. Luteolin can be obtained from naringinin by the consecutive action of a flavone synthase (I or II) (E.C. 1.14.20.5) (E.C. 1.14.19.76), which will produce a double bond at C2 and C3, and a NADPH-dependent flavonoid 3′-hydroxylase (E.C. 1.14.14.82). A SAM-methyltransferase will methylate the hydroxyl group just added in 3′ of the B ring by the F3′H to form chrysoeriol and produce SAH. A geranyltransferase and a prenyltransferase will add their respective group on the C7 of the A ring of chrysoeriol, to obtain cannflavins A and B, respectively. To produce cannflavin C, a geranyltransferase adds its geranyl group to C-9 of the A ring of chrysoeriol.
Figure 12 Biosynthesis of cannflavins. FNSI/II, flavone synthase I and II. F3′H, flavonoid 3′-hydroxylase. Arrow represents one biochemical reaction. SAM-MT, S-adenosyl-L-methionine methyltransferase. GT, geranyltransferase. PT, prenyltransferase. SAH, S-adenosyl-L-homocysteine. Luteolin can be obtained from naringinin by the consecutive action of a flavone synthase (I or II) (E.C. 1.14.20.5) (E.C. 1.14.19.76), which will produce a double bond at C2 and C3, and a NADPH-dependent flavonoid 3′-hydroxylase (E.C. 1.14.14.82). A SAM-methyltransferase will methylate the hydroxyl group just added in 3′ of the B ring by the F3′H to form chrysoeriol and produce SAH. A geranyltransferase and a prenyltransferase will add their respective group on the C7 of the A ring of chrysoeriol, to obtain cannflavins A and B, respectively. To produce cannflavin C, a geranyltransferase adds its geranyl group to C-9 of the A ring of chrysoeriol.CC BY · PubMed Central
Figure 13 Classification of stilbenes identified in Cannabis according to their chemical structure.
Figure 13 Classification of stilbenes identified in Cannabis according to their chemical structure.CC BY · PubMed Central
Figure 14 General biosynthesis pathway of Cannabis stilbenes. (A) Enzymatic reaction for the production of resveratrol. Arrow represents one biochemical reaction. STS, stilbene synthase. Stilbene synthase (2.3.1.95) produces resveratrol and CO2 from p-coumaroyl-CoA by subsequent addition of three malonyl-CoA molecules, and their cyclization, releasing four CO2 molecules. (B) Enzymatic reactions carried out in Cannabis for the production of stilbenes. DBR, double bond reductase. BBS, bibenzyl synthase. Note that the resulting structures of the oxidative coupling reactions (i.e., phenanthrenes and spiroindans) were conceived using the structure of dihydroresveratrol for simplicity. Double bond reductase (E.C. 1.3.1.117) produces dihydro-p-coumaroyl-CoA from p-coumaroyl-CoA and dihydrocaffeoyl-CoA from caffeoyl-CoA through NAD(P)H oxidation. BBS (E.C. 1.3.1.74) produces dihydroresveratrol from dihydro-p-coumaroyl-CoA and dihydropiceatannol from dihydrocaffeoyl-CoA, through addition and cyclization of three subsequent malonyl-CoA molecules, releasing four CO2 molecules. From dihydrostilbenes, different oxidative coupling reactions can take place, producing phenanthrenes (o-o coupling) and spiroindans (o-p and p-p coupling).
Figure 14 General biosynthesis pathway of Cannabis stilbenes. (A) Enzymatic reaction for the production of resveratrol. Arrow represents one biochemical reaction. STS, stilbene synthase. Stilbene synthase (2.3.1.95) produces resveratrol and CO2 from p-coumaroyl-CoA by subsequent addition of three malonyl-CoA molecules, and their cyclization, releasing four CO2 molecules. (B) Enzymatic reactions carried out in Cannabis for the production of stilbenes. DBR, double bond reductase. BBS, bibenzyl synthase. Note that the resulting structures of the oxidative coupling reactions (i.e., phenanthrenes and spiroindans) were conceived using the structure of dihydroresveratrol for simplicity. Double bond reductase (E.C. 1.3.1.117) produces dihydro-p-coumaroyl-CoA from p-coumaroyl-CoA and dihydrocaffeoyl-CoA from caffeoyl-CoA through NAD(P)H oxidation. BBS (E.C. 1.3.1.74) produces dihydroresveratrol from dihydro-p-coumaroyl-CoA and dihydropiceatannol from dihydrocaffeoyl-CoA, through addition and cyclization of three subsequent malonyl-CoA molecules, releasing four CO2 molecules. From dihydrostilbenes, different oxidative coupling reactions can take place, producing phenanthrenes (o-o coupling) and spiroindans (o-p and p-p coupling).CC BY · PubMed Central
Figure 15 Structure of some polyamines from the three different types: diamines, triamines, and tetraamines.
Figure 15 Structure of some polyamines from the three different types: diamines, triamines, and tetraamines.CC BY · PubMed Central
Figure 16 Chemical structure of Cannabis stilbenes HM1, HM2, and HM3.
Figure 16 Chemical structure of Cannabis stilbenes HM1, HM2, and HM3.CC BY · PubMed Central

Verification

Claims the paper makes

67 Valid · 10 Not valid · 122 Not checked · 42 Own results and interpretations

92 more claims · 23 with their cited sources checked

Create a free account to see all 241 claims and to verify the 9 references still open.

See all claims — free account
  • It may state two separate claims as one. 105
  • Probably not a substantial claim. 64
  • The quote only partly states this claim. 2

Create a free account to see these claims.

Citations

Cites

Show all 130 references

Research works printed but not linked: 2

  1. Deya, P., Kumarb, A., Guptac, M., Leea, B.M., Bhaktad, T., Dashd, S., and Kima, H.S. (2020). Recent Advances in Natural Products Analysis, Elsevier.
  2. NAS National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Population Health and Public Health Practice, and Committee on the Health Effects of Marijuana: An Evidence Review and Research Agenda (2025, April 27). Challenges and Barriers in Conducting Cannabis Research, The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research, Available online: https://www.ncbi.nlm.nih.gov/books/NBK425757/.

Cited by

See all 23

Metadata

Authors
Boucher, R., Germain, H., & Desgagné-Penix, I.
Affiliations
  • Université du Québec à Trois-Rivières (CA)
  • Department of Chemistry, Biochemistry and Physics, Université du Québec à Trois-Rivières, Trois-Rivières, QC G9A 5H7, Canada
Venue
Plants
Publisher
MDPI AG
Published
2025-04-30
Volume
14
Issue
9
Pages
1372
ISSN
2223-7747 (ISSN-L)
OpenAlex
W4410006496
Cited by
23
References
130
Citations by year
2026: 18 · 2025: 5
FWCI
3.09
Type
journal article
Language
en
Open access
Locations
  • Plants (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Le dépôt institutionnel (Université du Québec à Trois-Rivières) (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Université du Québec à Trois-Rivières (Annexe C)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
  • Life Sciences › Agricultural and Biological Sciences › Plant Science › Phytochemistry and Biological Activities
  • Life Sciences › Agricultural and Biological Sciences › Plant Science › Medicinal Plant Research
Keywords
cannabis, Cannabis sativa, phytochemicals, spermidine alkaloids, hydroxycinnamic acid amides, N-trans-feruloyltyramine, stilbenes, flavonoids, phenolic compounds, biosynthetic pathway, neuroprotection, anti-aging, antioxidant activity, anti-inflammatory activity, antiproliferative activity, therapeutic potential

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Exploring the Lesser-Known Bioactive Natural Products of Plant Species of the Genus Cannabis L.: Alkaloids, Phenolic Compounds, and Their Therapeutic Potential. https://app.cochat.ai/papers/10.3390/plants14091372
The paper
Boucher, R., Germain, H., & Desgagné-Penix, I. (2025). Exploring the Lesser-Known Bioactive Natural Products of Plant Species of the Genus Cannabis L.: Alkaloids, Phenolic Compounds, and Their Therapeutic Potential. Plants. https://doi.org/10.3390/plants14091372

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.